Topic 81 of 138 in the MU Sofia syllabus for Internal Diseases and Therapy (Medicine, Years 4 and 5). The free AceMed note covers it in 13 sections, about 1,232 words (12 min of reading), with 18 flashcards.
In this note
In brief
Definition
Epidemiology
Etiology
Pathogenesis
Clinical features
Diagnosis
Differential diagnosis
Treatment
Complications
Prognosis
Exam lens: USMLE / PLAB
References
In brief
What it is: a raised serum prolactin, from physiological causes, drugs, other diseases (primary hypothyroidism, kidney failure) or a pituitary tumour. The prolactinoma (a lactotroph adenoma) is the commonest hormone-secreting pituitary tumour.
Key to diagnosis: confirm the high level, then exclude pregnancy, drugs, hypothyroidism and macroprolactin before the MRI. A prolactin above about 200 µg/L usually means a prolactinoma; a large mass with a modest rise suggests the stalk effect.
Key to treatment: a dopamine agonist, cabergoline first, normalises prolactin and shrinks the tumour in most patients. Surgery is for resistance, intolerance or an expanding tumour.
Definition
Hyperprolactinaemia: serum prolactin above the laboratory's upper limit (about 25 µg/L in women and 20 µg/L in men, or 500 and 400 mIU/L; units and ranges differ between assays). The mild rises seen with stress, sleep or a hard blood draw have little meaning.
Prolactinoma: a benign tumour of the pituitary's prolactin-making cells. Microprolactinoma: below 10 mm. Macroprolactinoma: 10 mm or more; above 40 mm is a giant prolactinoma.